An interventional study of Research Pharmacist in Hypertension, sponsored by University of Iowa. Completed at 1 site in United States. Open to female participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-08-29.
Sponsored by University of Iowa · Not applicable, Interventional, and Screening
The goal of this clinical trial is to learn if a research pharmacist can improve the health of new mothers and their babies. The main questions it aims to answer are:
Participants will:
6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.
This study's enrollment of 25 is below the median of 90 across 4,995 interventional studies indexed under Hypertension.
Browse Hypertension studies →University of Iowa is the lead sponsor of 276 studies on the registry; 35 are open to participants now.
Of its 44 completed or terminated interventional studies of FDA-regulated products, 39 (89%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Behavioral: Research Pharmacist
The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
Number of Participants Who Talk to Research Pharmacist
We will calculate the number of participants who talk to the research pharmacist during the course of the intervention.
Time frame: Through study completion, an average of 30 days
Number of Participants Who Return BP Measurements
We will calculate the number of participants who return at least one blood pressure measurement via text message.
Time frame: Through study completion, an average of 30 days
Percentage of Well-Child Visits Attended
We will calculate the percentage of well-child visits that are attended by each family.
Time frame: Through study completion, an average of 30 days
Percentage of Vaccinations Received
We will calculate the percentage of vaccinations received by each child.
Time frame: Through study completion, an average of 30 days
Number of BP Measurements Submitted
We will calculate the number of blood pressure values that are submitted by each participant.
Time frame: Through study completion, an average of 30 days
Blood Pressure Control
We will determine how many participants' blood pressure is controlled after the intervention.
Time frame: Through study completion, an average of 30 days
Number of Participants Satisfied With the Study
We will measure participant satisfaction with the study using an exit survey. Satisfaction will be measured by a response of Extremely Helpful or Helpful on the question- My contact(s) with the pharmacist about my health were....
Time frame: Through study completion, an average of 30 days
| Milestone | Research Pharmacist Monitoring |
|---|---|
| Started | 25 |
| Completed | 23 |
| Not completed | 2 |
| Withdrew: Withdrawal by subject | 2 |
We will calculate the number of participants who talk to the research pharmacist during the course of the intervention.
| Participants | Research Pharmacist Monitoring |
|---|---|
| Number of Participants Who Talk to Research Pharmacist | 20 |
We will calculate the number of participants who return at least one blood pressure measurement via text message.
| Participants | Research Pharmacist Monitoring |
|---|---|
| Number of Participants Who Return BP Measurements | 22 |
We will calculate the percentage of well-child visits that are attended by each family.
| Well-child visits | Research Pharmacist Monitoring |
|---|---|
| Percentage of Well-Child Visits Attended | 57 |
We will calculate the percentage of vaccinations received by each child.
| Vaccinations | Research Pharmacist Monitoring |
|---|---|
| Percentage of Vaccinations Received | 251 |
We will calculate the number of blood pressure values that are submitted by each participant.
| Mean Number of Blood Pressure Values | Research Pharmacist Monitoring |
|---|---|
| Number of BP Measurements Submitted | 12.9 ± 5.3 |
We will determine how many participants' blood pressure is controlled after the intervention.
| Participants | Research Pharmacist Monitoring |
|---|---|
| Blood Pressure Control | 12 |
We will measure participant satisfaction with the study using an exit survey. Satisfaction will be measured by a response of Extremely Helpful or Helpful on the question- My contact(s) with the pharmacist about my health were....
| Participants | Research Pharmacist Monitoring |
|---|---|
| Number of Participants Satisfied With the Study | 7 |
Collected over 1 month. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Research Pharmacist Monitoring | 0/25 (0%) | 0/25 (0%) | 0/25 (0%) |
| Age, Continuous(years) | Research Pharmacist Monitoring |
|---|---|
| Mean | 32.4 ± 4.8 |
| Sex: Female, Male(Participants) | Research Pharmacist Monitoring |
|---|---|
| Female | 25 |
| Male | 0 |
| Ethnicity (NIH/OMB)(Participants) | Research Pharmacist Monitoring |
|---|---|
| Hispanic or Latino | 2 |
| Not Hispanic or Latino | 23 |
| Unknown or Not Reported | 0 |
| Race (NIH/OMB)(Participants) | Research Pharmacist Monitoring |
|---|---|
| American Indian or Alaska Native | 0 |
| Asian | 2 |
| Native Hawaiian or Other Pacific Islander | 1 |
| Black or African American | 3 |
| White | 17 |
| More than one race | 0 |
| Unknown or Not Reported | 2 |
| Education(Participants) | Research Pharmacist Monitoring |
|---|---|
| High School | 1 |
| Some College/Associate's | 5 |
| Bachelor's | 11 |
| Master's | 6 |
| Doctoral Degree | 2 |
Documents are hosted by the registry — open the source record to download them.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Iowa